This inventor holds 1 USPTO granted patent. Top assignee: Ursapharm Arzneimittel Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Peter Gross and His Patent Work in Bromelain-Based Coronavirus Treatments.
Introduction
Peter Gross is an inventor associated with Pirmasens, Germany, and Ursapharm Arzneimittel GmbH. His patent work concerns a proposed treatment or prophylaxis for coronavirus infections in humans or animals.
Latest Patents
The supplied information lists one patent for Peter Gross. It covers bromelain protease, bromelain, jacalin-like lectin, pineapple stem and/or fruit extracts, combination preparations, bromelain protease inhibitors, protein/protease mixtures, and glycated bromelain protein formed through exogenous non-enzymatic glycation, for use in treating or preventing coronavirus infections.
Career Highlights
Gross’s listed patent reflects research into pineapple-derived compounds and protein-based preparations for potential antiviral applications. The supplied information identifies him as an inventor on 1 patent.
Collaborations
The information provided names Ursapharm Arzneimittel GmbH as the company associated with Gross and Rolf Müller as his coworker.
Conclusion
Peter Gross’s listed invention explores bromelain-related ingredients and preparations for potential use against coronavirus infections in humans and animals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile